CIK 0001088856 · Large accelerated filer
CORCEPT THERAPEUTICS INC
Sign in to watch- Ticker
- CORT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770487658
- Phone
- 650.688.8803
- Business address
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $40,016,521
- in 15 filings, $36.7M under 10b5-1 plans
Net −$40,016,521. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-06-03 | BAKER G LEONARD JR Director | Option exercise | +30,000 | $0.96 | $29K | 1,026,838 |
| 2019-06-03 | BAKER G LEONARD JR Director | Sale | −30,000 | $9.78 | $293K | 996,838 |
| 2019-06-03 | BAKER G LEONARD JR Director | Option exercise · Stock Option (Right To Buy) | −30,000 | 0 | ||
| 2019-06-03 | MAHONEY DAVID L Director | Option exercise | +50,000 | $0.96 | $48K | 50,000 |
| 2019-06-03 | MAHONEY DAVID L Director | Option exercise · Stock Option (Right to Buy) | −50,000 | 0 | ||
| 2019-04-01 | Grauer Andreas Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +425,000 | 425,000 | ||
| 2019-03-20 | BELANOFF JOSEPH K Chief Executive Officer | Option exercise | +782,885 | $1.19 | $932K | 2,947,080 |
| 2019-03-20 | BELANOFF JOSEPH K Chief Executive Officer | Shares withheld for taxes | −427,528 | $11.93 | $5.1M | 2,519,552 |
| 2019-03-20 | BELANOFF JOSEPH K Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −782,885 | 0 | ||
| 2019-03-07 | WILSON JAMES N Director | Option exercise | +105,782 | $2.30 | $243K | 115,782 |
| 2019-03-07 | WILSON JAMES N Director | Option exercise · Stock Option (Right to Buy) | −105,782 | 284,218 | ||
| 2019-02-25 | WILSON JAMES N Director | Gift | −13,628 | 1,331,574 | ||
| 2019-02-12 | BAKER G LEONARD JR Director | Purchase | +30,000 | $11.39 | $342K | 996,838 |
| 2019-02-12 | BAKER G LEONARD JR Director | Purchase | +70,000 | $11.39 | $797K | 3,114,793 |
| 2019-02-08 | Maduck Sean See Remarks | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2019-02-08 | BELANOFF JOSEPH K Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +475,000 | 475,000 | ||
| 2019-02-08 | Robb Gary Charles Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2019-02-07 | BRADBURY DANIEL Director | Gift | −25,000 | 130,575 | ||
| 2018-12-26 | Robb Gary Charles Chief Financial Officer | Gift | +1,167 | 2,735 | ||
| 2018-12-26 | Robb Gary Charles Chief Financial Officer | Gift | +1,167 | 2,735 |
Page 67 of 72 · 1,435 trades